Effects of Phosgene Exposure on Lung Arachidonic Acid Metabolism

References

• Albert H., Snyder F. Biosynthesis of l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) from l-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macro-phages. Biol. Chem. 1983; 258: 97–102
   Web of Science ®Google Scholar
• Ah A. E., Barrett J. C., Eling T. E. Prostaglandin and thromboxane production by fibro-blasts and vascular endothelial cells. Prostaglandins 1980; 20: 667–688
   PubMedGoogle Scholar
• Bowden D. H. The alveolar macrophage. Environ. Health Perspect. 1984; 55: 327–341
   PubMed Web of Science ®Google Scholar
• Burleson G. R., Keyes L. L. Natural killer activity in Fischer-344 rat lungs as a method to assess pulmonary immunocompetence: Immunosuppression by phosgene inhalation. Im-munopharmacol. Immunotoxicol. 1989; 11: 421–443
   PubMed Web of Science ®Google Scholar
• Churchill L., Chilton F. H., Resau I. H., Bascom R., Hubbard W. C., Proud D. Cyclooxy-genase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am. Rev. Respir. Dis. 1989; 140: 449–459
   PubMed Web of Science ®Google Scholar
• Damon M., Chavis C., de Paulet A. C., Codard P. H. Arachidonic acid metabolism in alveolar macrophages. A comparison of cells from healthy subjects, allergic asthmatics, and chronic bronchitis patients. Prostaglandins 1987; 34: 291–309
   PubMed Web of Science ®Google Scholar
• Diller W. F. Pathogenesis of phosgene poisoning. Toxicol. Ind. Health 1985a; 1: 7–15
   PubMedGoogle Scholar
• Diller W. F. Late sequelae after phosgene poisoning. Toxicol. Ind. Health 1985b; 1: 129–137
   PubMedGoogle Scholar
• Downey G. P., Cumbay R. S., Doherty D. E., LaBrecque J. F., Henson J. E., Henson P. M., Worthen G. S. Enhancement of pulmonary inflammation by PCE,: Evidence for a vasodilator effect. J. Appl. Physiol. 1988; 64: 728–741
   PubMed Web of Science ®Google Scholar
• Ehrlich J. P., Gunnison A. F., Burleson C. R. Influenza virus-specific cytotoxic T lymphocyte (CTL) activity in Fischer-344 rat lungs as a method to assess pulmonary immunocompetence: Effect of phosgene inhalation. Inhal. Toxicol. 1989; 1: 129–138
   Google Scholar
• Franch S., Hatch C. E. Pulmonary biochemical effects of inhaled phosgene in rats. J. Toxicol. Environ. Health 1986; 19: 413–423
   PubMed Web of Science ®Google Scholar
• Frosolono M. F., Pawlowski R. Effect of phosgene on rat lungs after single high-level exposure. II. Ultrastructural alterations. Arch. Environ. Health 1977; 32: 278–283
   PubMedGoogle Scholar
• Cross P., Rinehart W. E., Hatch T. Chronic pneumonitis caused by phosgene. Arch. Environ. Health 1965; 10: 768–775
   PubMedGoogle Scholar
• Henderson W. R., Jr. Eicosanoids and lung inflammation. Am. Rev. Respir. Dis. 1987; 135: 1176–1185
   PubMed Web of Science ®Google Scholar
• Henderson W. R., Klebanoff S. J. Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperidase-deficient neutrophils. J. Biol. Chem. 1983; 258: 13522–13527
   PubMed Web of Science ®Google Scholar
• Henke D., Danilowicz R., Eling T. Arachidonic acid metabolism by isolated epidermal basal and differentiated keratinocytes from the hairless mouse. Biochirn. Biophys. Acta 1986; 876: 271–279
   PubMed Web of Science ®Google Scholar
• Hunninghake G. W., Kawanami O., Ferrans V. I., Young R. C., Jr, Roberts W. C., Crystal R. C. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am. Rev. Respir. Dis. 1981; 123: 407–412
   PubMed Web of Science ®Google Scholar
• Koren H. S., Devlin R. B., Graham D. E., Mann R., McCee M. P., Horstman D. H., Kozumbo W. J., Becker S., House D. E., McDonnell W. F., Bromberg P. A. Ozone-induced inflammation in the lower airways of human subjects. Am. Rev. Respir. Dis. 1989; 139: 407–415
   PubMed Web of Science ®Google Scholar
• Kouzan S., Brody A. R., Nettesheim P., Eling T. Production of arachidonic acid metabolites by macrophages exoposed in vitro to asbestos, carbonyl iron particles, or calcium ionophore. Am. Rev. Respir. Dis. 1985; 131: 624–632
   PubMed Web of Science ®Google Scholar
• Laviolette M., Chang J., Newcombe D. S. Human alveolar macrophages: A lesion in arachidonic acid metabolism in cigarette smokers. Am. Rev. Respir. Dis. 1981; 124: 397–401
   PubMedGoogle Scholar
• Leikauf C. D., Driscoll K. E., Wey H. E. Ozone-induced augmentation of eicosanoid metabolism in epithelial cells from bovine trachea. Am. Rev. Respir. Dis. 1988; 137: 435–442
   PubMed Web of Science ®Google Scholar
• Leung K. H., Ip M. M. Regulation of rat natural killing. Inhibition of cytolysis and activation by inhibitors of lipoxygenase. Possible role of leukotrienes. Cell. Immunol. 1986; 100: 474–484
   PubMed Web of Science ®Google Scholar
• Leung K. H., Ip M. M., Koren H. S. Regulation of human natural killing. Role of lipoxygenase in regulation of natural killing activity. Scand. J. Immunol. 1986; 24: 371–380
   PubMed Web of Science ®Google Scholar
• Levine L., Alam I. Arachidonic acid metabolism by cells in culture: Analysis of culture fluids for cyclooxygenase products by radioimmunoassay before and after separation by high pressure liquid chromatography. Prostaglandins Med. 1979; 3: 295–304
   PubMedGoogle Scholar
• Lewis G. P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br. Med. Bull. 1983; 39: 243–248
   PubMed Web of Science ®Google Scholar
• Martin W. J. Neutrophils kill pulmonary endothelial cells by a hydrogen peroxide-dependent pathway. Am. Rev. Respir. Dis. 1984; 130: 209–213
   PubMed Web of Science ®Google Scholar
• Matthay M. A., Eschenbacher W. L., Goetzl E. J. Elevated concentrations of leukotriene D4 in pulmonary edema of patients with adult respiratory distress syndrome. J. Clin. Immunol. 1984; 4: 479–483
   PubMed Web of Science ®Google Scholar
• Monick M., Glazier J., Hunninghake C. W. Human alveolar macrophages suppress interleukin-1 (IL-I) activity via the secretion of prostaglandin E. Am. Rev. Respic Dis. 1987; 135: 66–71
   PubMedGoogle Scholar
• Paredes J. M., Weiss S. J. Human neutrophils transform prostaglandins by a rnyeloperoxidase-dependent mechanism. J. Biol. Chem. 1982; 257: 2738–2740
   PubMed Web of Science ®Google Scholar
• Parker C. W. Lipid mediators produced through the lipoxygenase pathway. Annu. Rev. Immunol. 1987; 5: 54–84
   Web of Science ®Google Scholar
• Pawlowski R., Frosolongo M. F. Effects of phosgene on rat lungs after single high level exposure. Arch Environ. Health 1977; 32: 278–283
   PubMed Web of Science ®Google Scholar
• Pitchenik A. E., Guffee I., Stein-Streilein J. Lung natural killer and interleukin-2 activity in lung cancer. Am. Rev. Respic Dis. 1987; 136: 1327–1332
   PubMedGoogle Scholar
• Rola-Pleszcynski M., Gagnon L., Bolduc D., LeBreton G. Evidence for the involvement of the thrornboxane synthase pathway in human natural cytotoxic cell activity. J. Immunol. 1985; 135: 4114–4119
   PubMedGoogle Scholar
• Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflarnmation. Science 1983; 220: 568–575
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. SAS User's Guide: Statistics, Version 5 Edition. SAS Institute, Inc., Cary, N.C. 1985
   Google Scholar
• Scott W. A., Zrike J. M., Hamill A. L., Kempe I., Cohn Z. A. Regulation of arachidonic acid metabolites in macrophages. J. Exp. Med. 1980; 152: 324–335
   PubMed Web of Science ®Google Scholar
• Selgrade M. K., Starnes D. M., Illing J. W., Daniels M. J., Graham J. A. Effects of phosgene on bacterial, viral, and neoplastic lung disease susceptibility in mice. Inhal. Toxicol. 1989; 1: 243–259
   Google Scholar
• Smith M. J.H., Ford-Hutchinson A. W., Bray M. A. Leukotriene B: A potential mediator of inflammation. J. Pbarm. Pharmacol. 1980; 32: 517–518
   PubMed Web of Science ®Google Scholar
• Snedecor G. W., Cochran W. C. Statistical Methods, 6th ed. Iowa State University Press, Arnes 1978
   Google Scholar
• U.S. Environmental Protection Agency. Health Assessment Document for Phosgene. EPA/600/8–86/022A, Washington, D.C. 1986
   Google Scholar
• Wright J. L., Lawson L. M., Pare P. D., Kennedy S., Wiggs B., Hogg J. C. The detection of small airways disease. Am. Rev. Respic Dis. 1984; 129: 989–994
   PubMed Web of Science ®Google Scholar